Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare
Seres Therapeutics, Inc. Price to FCF Ratio 2015–2026
Price to free cash flow (P/FCF) ratio for Seres Therapeutics, Inc. (MCRB): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 98.26.
From: 09/30/2015To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Seres Therapeutics, Inc. Price to FCF Ratio — FAQ
Seres Therapeutics, Inc. (MCRB) price to fcf ratio over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MCRB's price to fcf ratio history?
The chart and table above show Seres Therapeutics, Inc.'s price to fcf ratio by year and by quarter, including the growth rate.